Get startedLog in
    Picture of Avadel Pharmaceuticals logo

    AVDL — Avadel Pharmaceuticals News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousMid CapHigh Flyer
    All News

    Brief: Avadel Pharmaceuticals Reiterates 2025 Guidance

    Picture of Avadel Pharmaceuticals logoAvadel Pharmaceuticals
    03/03/2025 12:16
    March 3 (Reuters) - Avadel Pharmaceuticals AVDL.O:

REITERATES 2025 GUIDANCE WITH $240-$260 MILLION REVENUE

AVADEL PHARMACEUTICALS - Q4 REVENUE $50.4 MILLION

Q4 LOSS PER SHARE $0.05

Q4 EARNINGS PER SHARE VIEW $-0.04, REVENUE VIEW $50.0 MILLION -- LSEG IBES DATA

Source text: [ID:n0001104659-25-019463]

Further company coverage: AVDL.O

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Avadel Pharmaceuticals

    See all news